Tarsus Pharmaceuticals Correlations
TARS Stock | USD 46.40 0.18 0.39% |
The current 90-days correlation between Tarsus Pharmaceuticals and ZyVersa Therapeutics is -0.13 (i.e., Good diversification). The correlation of Tarsus Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Tarsus Pharmaceuticals Correlation With Market
Average diversification
The correlation between Tarsus Pharmaceuticals and DJI is 0.18 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Tarsus Pharmaceuticals and DJI in the same portfolio, assuming nothing else is changed.
Tarsus |
Moving together with Tarsus Stock
0.75 | VERA | Vera Therapeutics | PairCorr |
0.85 | DRUG | Bright Minds Biosciences | PairCorr |
0.78 | SABSW | SAB Biotherapeutics | PairCorr |
0.67 | DVAX | Dynavax Technologies | PairCorr |
0.62 | VRDN | Viridian Therapeutics | PairCorr |
0.94 | VRNA | Verona Pharma PLC | PairCorr |
0.96 | VSTM | Verastem | PairCorr |
Moving against Tarsus Stock
0.88 | VINC | Vincerx Pharma | PairCorr |
0.84 | VRCA | Verrica Pharmaceuticals | PairCorr |
0.83 | VALN | Valneva SE ADR Downward Rally | PairCorr |
0.82 | DTIL | Precision BioSciences | PairCorr |
0.81 | ME | 23Andme Holding | PairCorr |
0.77 | VIRX | Viracta Therapeutics | PairCorr |
0.7 | DRMA | Dermata Therapeutics | PairCorr |
0.65 | VRAX | Virax Biolabs Group | PairCorr |
0.56 | VCNX | Vaccinex | PairCorr |
0.54 | DYAI | Dyadic International | PairCorr |
0.48 | DRRX | Durect | PairCorr |
0.91 | EDSA | Edesa Biotech Fiscal Year End 20th of December 2024 | PairCorr |
0.82 | VXRT | Vaxart Inc | PairCorr |
0.78 | EDIT | Editas Medicine | PairCorr |
0.76 | EPIX | ESSA Pharma Fiscal Year End 10th of December 2024 | PairCorr |
0.69 | CDTTW | Conduit Pharmaceuticals | PairCorr |
0.66 | VTGN | VistaGen Therapeutics | PairCorr |
0.65 | ELAN | Elanco Animal Health Sell-off Trend | PairCorr |
0.59 | ENTA | Enanta Pharmaceuticals | PairCorr |
0.51 | ELEV | Elevation Oncology | PairCorr |
0.47 | ENVB | Enveric Biosciences | PairCorr |
0.46 | ELUT | Elutia Inc | PairCorr |
0.41 | EOLS | Evolus Inc | PairCorr |
Related Correlations Analysis
0.68 | -0.08 | 0.34 | -0.19 | -0.05 | ZVSA | ||
0.68 | 0.03 | 0.55 | -0.22 | -0.02 | SONN | ||
-0.08 | 0.03 | 0.25 | 0.54 | 0.29 | ZURA | ||
0.34 | 0.55 | 0.25 | 0.14 | -0.14 | PHIO | ||
-0.19 | -0.22 | 0.54 | 0.14 | -0.03 | RNAZ | ||
-0.05 | -0.02 | 0.29 | -0.14 | -0.03 | QNRX | ||
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Tarsus Stock performing well and Tarsus Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Tarsus Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
ZVSA | 4.67 | (0.99) | 0.00 | 0.60 | 0.00 | 9.17 | 78.93 | |||
SONN | 4.76 | (0.77) | 0.00 | 2.19 | 0.00 | 12.31 | 37.58 | |||
ZURA | 3.78 | (0.36) | 0.00 | (0.09) | 0.00 | 7.95 | 30.69 | |||
PHIO | 4.53 | (0.30) | 0.00 | (0.18) | 0.00 | 11.78 | 36.22 | |||
RNAZ | 7.63 | 1.05 | 0.10 | (0.44) | 6.52 | 22.00 | 68.80 | |||
QNRX | 6.21 | 0.47 | 0.07 | 0.37 | 6.73 | 17.65 | 74.46 |
Tarsus Pharmaceuticals Corporate Management
Leonard JD | Chief Officer | Profile | |
Scott Youmans | Vice Sales | Profile | |
Seshadri Neervannan | Chief Officer | Profile | |
Adrienne Kemp | Senior Communications | Profile | |
Elizabeth MD | Chief Director | Profile | |
Aziz MBA | Chief Officer | Profile |